/

Strand Therapeutics

Developing programmable mRNA-based immunotherapies for cancer treatment.

BiotechnologyPharmaceuticals strandtx.com ↗

Company facts

Founded: 2017
Employees: 113
Headquarters: United States
Type: Private
Funding: Series B · $153M · 2025